NORD Announces 2016 Grant Opportunities

NORD has announced its 2016 requests for proposals for research studies related to the following rare diseases:

• Alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV)
• Appendix cancer and pseudomyxoma peritonei (PMP)
• Autoimmune polyglandular syndrome type 1 (APS Type 1)
• Homocystinuria due to cystathionine beta-synthase deficiency
• Malonic aciduria
• Stiff person syndrome

The object of the NORD Research Grant Program is to encourage meritorious scientific and clinical research that will lead to new diagnostics, treatments, and/or cures for rare diseases. NORD’s Research Grant Program provides seed grants to clinicians and academic scientists for translational or clinical studies. Data generated in these studies may then be used by researchers to obtain additional funding from government or industry sponsors. Two of NORD’s previous research grants have resulted in FDA-approved orphan products to treat rare diseases.

The deadline to submit letters of intent for all grants except the ACD/MPV grant is September 12. The deadline for letters of intent for the ACD/MPV grant is October 21. Submissions should be sent to research@rarediseases.org. Click here to view each RFP in full.